info@mail.ucallm.com
From Lipid Metabolic Regulation to Disease Mechanisms — Empowering Comprehensive Lipid Biology Research with Validated Metabolic Marker Antibody Solutions
Lipid metabolism is a highly coordinated biological network that regulates energy storage, membrane organization, signaling molecule production, and cellular adaptation to environmental changes. Beyond serving as essential structural and energetic components, lipids function as dynamic signaling mediators that control cell proliferation, inflammation, immune responses, mitochondrial function, and metabolic homeostasis.
Lipid metabolic regulation involves interconnected processes including de novo lipogenesis, fatty acid oxidation, lipid droplet formation, lipid storage, and lipid mobilization. These pathways are precisely controlled by metabolic enzymes, transcriptional regulators, lipid transport proteins, and organelle-associated signaling networks.
Dysregulated lipid metabolism contributes to diverse biological and pathological processes, including:
· Metabolic dysfunction-associated steatotic liver disease (MASLD/NAFLD)
· Obesity and insulin resistance
· Cancer metabolic reprogramming and tumor progression
· Tumor microenvironment remodeling and immune suppression
· Cardiovascular disease and lipid-associated disorders
· Ferroptosis and oxidative stress regulation
· Inflammatory disorders and immune-cell metabolic adaptation
We provide comprehensive antibody solutions for investigating lipid biology—from metabolic pathway characterization and enzyme expression profiling to lipid storage regulation, mitochondrial fatty acid oxidation, and disease-associated metabolic remodeling.
Validated lipid metabolism antibodies enable researchers to characterize:
· De novo fatty acid synthesis pathways
· Mitochondrial fatty acid oxidation programs
· Lipid droplet formation and turnover mechanisms
· Cholesterol and triglyceride metabolism regulation
· Metabolic signaling networks controlling lipid homeostasis
· Cancer-associated and immune-associated metabolic adaptations
By integrating high-quality metabolic antibodies with advanced molecular profiling approaches, researchers can decode complex lipid regulatory networks and accelerate discoveries in metabolism research, cancer biology, immunometabolism, liver disease, cardiovascular research, and precision medicine.
Lipid Metabolism Biomarker Antibody Portfolio
——Comprehensive Solutions for Lipid Pathway Mapping, Metabolic Regulation, and Disease Mechanism Discovery
Precise analysis of lipid metabolism requires integrated profiling of lipogenic enzymes, fatty acid oxidation regulators, lipid droplet-associated proteins, and metabolic transcription networks.
Our antibody portfolio provides validated tools targeting key regulators across major lipid metabolic processes:
Research Focus | Representative Biomarkers | Research Applications |
De Novo Lipogenesis & Fatty Acid Synthesis | ACLY, ACSS2, ACACA, ACACB, FASN, SCD, SREBF1 (SREBP-1c), MLXIPL (ChREBP) | Investigation of lipid synthesis activation in cancer, MASLD, obesity, and metabolic disorders |
Cholesterol Biosynthesis & Regulation | HMGCR, SREBF2, SCAP, INSIG1, LDLR, SQLE | Analysis of cholesterol metabolism and sterol-regulated signaling |
Fatty Acid Oxidation & Mitochondrial Lipid Metabolism | CPT1A, CPT1B, CPT2, ACADL, ACADM, ACADVL, ETFDH, HADHA, ACOX1, PPARA, PPARGC1A, ESRRA | Characterization of mitochondrial fatty acid utilization and metabolic adaptation |
Energy-Sensing Lipid Regulation | PRKAA1/2, p-AMPKα (Thr172), p-ACACA (Ser79), MTOR, p-MTOR (Ser2448), SIRT1, PPARGC1A | Study of nutrient sensing and metabolic reprogramming |
Lipid Droplet Formation & Storage | PLIN1, PLIN2, PLIN3, PLIN4, PLIN5, DGAT1, DGAT2, FITM2 | Analysis of lipid storage organelles and lipid droplet biogenesis |
Lipolysis & Fatty Acid Mobilization | PNPLA2 (ATGL), LIPE (HSL), p-LIPE (Ser563/Ser660), MGLL, ABHD5 (CGI-58), G0S2 | Investigation of lipid breakdown and fatty acid release mechanisms |
Fatty Acid Uptake & Transport | CD36, FABP1, FABP4, SLC27A1 (FATP1), SLC27A2 (FATP2), SLC27A4 (FATP4) | Study of extracellular lipid uptake and metabolic flux regulation |
Core Lipid Metabolism Targets
——Molecular Function, Metabolic Regulation, and Disease Applications
Target | Biological Function | Research Significance |
ACLY | Generates cytosolic acetyl-CoA for lipid synthesis | Central metabolic node linking glucose metabolism with fatty acid synthesis |
ACC1/ACC2 | Produces malonyl-CoA and regulates fatty acid synthesis/oxidation balance | Rate-limiting control point of lipid metabolism |
FASN | Catalyzes palmitate synthesis from acetyl-CoA and malonyl-CoA | Frequently elevated in tumors and metabolic diseases |
SCD1 | Converts saturated fatty acids into monounsaturated fatty acids | Controls membrane lipid composition and tumor survival |
SREBP-1c | Master transcriptional regulator of lipogenic genes | Key driver of hepatic steatosis and metabolic remodeling |
HMGCR | Rate-limiting enzyme of cholesterol synthesis | Major regulator of cholesterol homeostasis |
CPT1A | Controls mitochondrial fatty acid entry | Essential regulator of mitochondrial β-oxidation |
PPARα | Activates fatty acid oxidation gene programs | Regulates hepatic and muscle lipid utilization |
PGC-1α | Promotes mitochondrial biogenesis and oxidative metabolism | Marker of mitochondrial metabolic adaptation |
AMPK | Energy-sensing kinase controlling lipid balance | Major regulator of metabolic stress responses |
DGAT1/2 | Catalyzes triglyceride synthesis | Controls lipid storage and lipid droplet formation |
ATGL (PNPLA2) | Initiates triglyceride hydrolysis | Key enzyme controlling lipid mobilization |
PLIN Family | Regulates lipid droplet structure and dynamics | Essential markers for lipid storage organelle biology |
CD36 | Mediates fatty acid uptake | Controls extracellular lipid supply and metabolic flux |
PLIN1 | Lipid droplet coating protein | Adipocyte lipid storage and lipolysis regulation |
PLIN2/ADRP | Neutral lipid storage regulation | Lipid accumulation marker in liver disease and macrophages |
PLIN5 | Mitochondria-lipid droplet interaction | Fatty acid oxidation coupling |
CIDEC/FSP27 | Lipid droplet expansion | Adipocyte hypertrophy and lipid storage |
SREBP2 | Cholesterol sensing transcription factor | Sterol homeostasis |
SQLE | Cholesterol biosynthesis enzyme | Cancer cholesterol metabolism |
ABCA1 | Cholesterol efflux transporter | Macrophage foam cell formation |
ABCG1 | HDL-mediated cholesterol transport | Atherosclerosis research |
Featured Lipid Metabolism Research Panels
——Comprehensive Antibody Panels for Lipid Pathway Profiling, Metabolic Remodeling, and Disease-Oriented Research
Lipid metabolism is regulated through coordinated interactions between metabolic enzymes, transcription factors, mitochondrial pathways, and lipid storage machinery. Our curated antibody panels enable systematic investigation of lipid synthesis, oxidation, storage, metabolic adaptation, and disease-associated lipid remodeling.
De Novo Lipogenesis & Metabolic Reprogramming Panel—Mapping Lipid Biosynthesis Activation and Metabolic Remodeling
Key Markers
ACLY | ACC1 | FASN | SCD1 | SREBP-1c | ChREBP | p-ACC |
Mitochondrial Fatty Acid Oxidation Panel—Characterizing Energy Utilization and Metabolic Adaptation
Key Markers
CPT1A | CPT1B | CPT2 | ACADL | ACADM | ACADVL |
ETFDH | HADHA | PPARA | PPARGC1A, |
|
|
Lipid Droplet Biology & Storage Regulation Panel—Investigating Lipid Storage Organelle Formation and Homeostasis
Key Markers
PLIN1 | PLIN2 | PLIN5 | DGAT1 | DGAT2 | FIT2 |
Lipolysis & Lipid Mobilization Panel—Analyzing Fatty Acid Release and Metabolic Remodeling
Key Markers
ATGL | HSL | MGLL | ABHD5 | G0S2 |
Immunometabolism & Cancer Lipid Adaptation Panel—Exploring Lipid-Driven Immune Regulation and Tumor Metabolism
Key Markers
CD36 | FABP4 | PPARγ | LXRα | SREBP1 | AMPK |
Why Researchers Choose Our Lipid Metabolism Antibody Solutions
Validated Metabolic Targets. Comprehensive Pathway Coverage. Reliable Research Outcomes.
Our antibody portfolio supports complete lipid metabolism research workflows:
Research Challenge | Our Solution |
How can I study abnormal lipid synthesis? | ACLY, ACC, FASN, SCD1, SREBP-1c panels |
How can I analyze mitochondrial fatty acid oxidation? | CPT1A, CPT2, PPARα, PGC-1α markers |
How can I investigate lipid storage mechanisms? | PLIN family, DGAT, FIT2 antibodies |
How can I study cancer lipid metabolism? | Lipogenesis and metabolic adaptation panels |
How can I explore immunometabolism? | CD36, AMPK, lipid signaling markers |
How can I improve reproducibility? | Validated antibodies optimized for WB, IF, IHC, and multiplex applications |
Key reference
1.Ludovic Enkler, Viktoria Szentgyörgyi (2023). Arf1 coordinates fatty acid metabolism and mitochondrial homeostasis.Nat Cell Biol. 2023 Aug;25(8):1157-1172.
2.Yuxuan Chen, Junyu Shen (2025). Dehydrocostus lactone suppresses gastric cancer progression by targeting ACLY to inhibit fatty acid synthesis and autophagic flux. J Adv Res. 2025 Jan:67:331-348.
3.Yutian Zhang, Tianlin Wang (2025) .Targeting the gut microbiota and lipid metabolism: potential mechanisms of natural products for the treatment of non-alcoholic fatty liver disease.Front Pharmacol, 2025 Jun 9:16:1610498.
4.Ying Sun, Kai Yan(2025).Advanced multifunctional nano-delivery platform focusing on treating diseases related to lipid metabolism via targeted intervention in various lipid metabolic processes. Military Medical Research,(2025) 12:87.
5.Tae Hyun Kim,Seong Hun Lim(2026). Metabolic crosstalk among cancer-associated fibroblasts, adipocytes and immune cells as an immunosuppressive tumor microenvironment driver. Experimental & Molecular Medicine (2026) 58:366–381.